Philip Morris International
Search results
Altria is a leading tobacco company that offers smoke-free products, such as e-cigarettes and oral nicotine pouches. Learn about its business strategies, sustainability efforts, community impact and investor relations.
- About Altria
Altria’s companies are leading the way in moving adult...
- Moving Beyond Smoking
At Altria, we're Moving Beyond Smoking TM. "In our view,...
- Responsibility
Altria’s tobacco companies are the undisputed market leaders...
- Investors
Investors. Our Vision is to responsibly lead the transition...
- People & Careers
At the Altria family of companies, we’re not content with...
- Reduce the Harm of Tobacco Products
To achieve our Vision, we are developing a portfolio of...
- Smoke-free Product Platforms
Altria’s companies are leading the way in moving adult...
- Communicating Tobacco Health Effects
*Altria Client Services Tobacco Harm Reduction (THR)...
- About Altria
Altria is the parent company of Philip Morris USA, John Middleton, Inc., U.S. Smokeless Tobacco Company, Inc., and Philip Morris Capital Corporation. Altria also maintains large minority stakes in Belgium-based brewer AB InBev and the Canadian cannabis company Cronos Group.
Find the latest Altria Group, Inc. (MO) stock quote, history, news and other vital information to help you with your stock trading and investing.
Altria is a FORTUNE 200 company that owns leading tobacco, alcohol and cannabis businesses in the U.S. and Canada. It aims to responsibly lead the transition of adult smokers to a smoke-free future and reduce the risk of tobacco products.
Get the latest Altria Group Inc (MO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Investors. Our Vision is to responsibly lead the transition of adult smokers to a smoke-free future. Our goal remains to balance investments in our future with returning cash to shareholders as we continue to build a smoke-free future. Press Releases.
Altria to receive cash payments from Philip Morris International of approximately $2.7 billion in exchange for assigning exclusive U.S. commercialization rights to the IQOS system effective April 30, 2024. Altria gains greater flexibility to allocate resources toward Moving Beyond Smoking .
